Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Mar 17, 2026, before the open
10-K filed Mar 17, 2026, 76 days after period end · 0001493152-26-010413
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $5.42M | — | $0.00 | $68.00K |
| Net Income | -$20.46M |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$9.29M |
| -$16.59M |
| -$7.12M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.